This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Joint Stock Company "Biocad". Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Anna Nikolaevna Strelkova: Innovator in Biomedicine
Introduction
Anna Nikolaevna Strelkova is a prominent inventor based in Yaransk, Russia. She has made significant contributions to the field of biomedicine, particularly in the development of innovative protein technologies. Her work is characterized by a commitment to advancing scientific knowledge and improving health outcomes.
Latest Patents
Anna holds a patent for the "Isolated Modified VP1 Capsid Protein of AAV5." This invention represents a crucial advancement in the understanding and application of adeno-associated viruses in therapeutic contexts. With 1 patent to her name, her contributions are noteworthy in the scientific community.
Career Highlights
Anna is currently employed at Biocad, a leading biopharmaceutical company in Russia. Her role involves research and development, where she applies her expertise to create innovative solutions in the field of medicine. Her dedication to her work has positioned her as a key figure in her organization.
Collaborations
Anna collaborates with Dmitrij Aleksandrovich Madera, a fellow researcher. Together, they work on projects that aim to push the boundaries of current scientific understanding and develop new therapeutic approaches.
Conclusion
Anna Nikolaevna Strelkova is a remarkable inventor whose work in biomedicine continues to impact the field positively. Her innovative spirit and dedication to research exemplify the qualities of a leading scientist.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile